Research advances in the pathogenesis and treatment of neurodegeneration with brain iron accumulation.
- Author:
Xiao-Su WANG
1
;
Li JIANG
1
Author Information
1. Department of Neurology, Children's Hospital of Chongqing Medical University/National Clinical Research Center for Child Health and Disorders/Ministry of Education Key Laboratory of Child Development and Disorders/Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China.
- Publication Type:Journal Article
- MeSH:
Basal Ganglia;
Basal Ganglia Diseases;
Brain;
Humans;
Iron;
Iron Metabolism Disorders/therapy*
- From:
Chinese Journal of Contemporary Pediatrics
2021;23(6):650-656
- CountryChina
- Language:Chinese
-
Abstract:
Neurodegeneration with brain iron accumulation (NBIA) is a group of rare neurogenetic degenerative diseases caused by genetic mutations and characterized by iron deposition in the central nervous system, especially in the basal ganglia, with an overall incidence rate of 2/1 000 000-3/1 000 000. Major clinical manifestations are extrapyramidal symptoms. This disease is presently classified into 14 different subtypes based on different pathogenic genes, and its pathogenesis and treatment remain unclear. This article summarizes the research advances in the pathogenesis and treatment of NBIA, so as to help pediatricians understand this disease and provide a reference for subsequent research on treatment.
